Wikidata

(Q42973648)

English

Characterisation of the cutaneous pathology in non-small cell lung cancer (NSCLC) patients treated with the EGFR tyrosine kinase inhibitor erlotinib

scientific article published on 2 June 2010

In more languages

Statements

title
Characterisation of the cutaneous pathology in non-small cell lung cancer (NSCLC) patients treated with the EGFR tyrosine kinase inhibitor erlotinib (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20621734
retrieved
12 November 2017
author name string
Alain Mita
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
20621734
retrieved
12 November 2017
Maja De Jonge
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
20621734
retrieved
12 November 2017
Lesley Matthews
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
20621734
retrieved
12 November 2017
Sean McCarthy
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
20621734
retrieved
12 November 2017
Kenneth K Iwata
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
20621734
retrieved
12 November 2017
Eric K Rowinsky
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
20621734
retrieved
12 November 2017
publication date
2 June 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
20621734
retrieved
12 November 2017
page(s)
2010-2019
1 reference
stated in
Europe PubMed Central
PubMed ID
20621734
retrieved
12 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42973648&oldid=1975568224"